U.S.-Asia Law Institute Research Scholar Chi Yin published an article, China's Non-Prosecution Mechanism: A Raft in China's Healthcare Anticorruption Campaign? in Thomson Reuters (Practical Law). She and her co-authors analyze China’s compliance-based non-prosecution mechanism from a comparative law perspective. They write that the mechanism could potentially shield some international pharmaceutical companies from criminal charges. Read more.